TNF and chronic obstructive pulmonary disease: Additionally, TNF-α stimulates lipolysis, increasing the circulation of free fatty acids (FFAs), which further impair insulin sensitivity and promote hepatic gluconeogenesis, contributing to worsening glycemic control in COPD-T2DM patients [16].